Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/Tissue plasminogen activator levels in myocardial infarction: A case-control study

Genetic Testing and Molecular Biomarkers

Volumn 14, Issue 1, 2010, Pages 23-27

  Abboud, Nesrine ^a   Ghazouani, Lakhdar ^a   Saidi, Sarra ^a   Ben Hadj Khalifa, Sonia ^a   Addad, Fawzi ^b   Almawi, Wassim Y ^c   Mahjoub, Touhami ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ALLELE; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; REGRESSION ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TUNISIA;

EID: 76949104147     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2009.0039     Document Type: Article

References (24)

1. Boekholdt SM, Bijsterveld NR, Moons AH, et al. (2001) Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation 104:3063-3068.
2. Dawson S, Hamsten A, Wiman B, et al. (1991) Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb 11:183-190.
3. Dawson SJ, Wiman B, Hamsten A, et al. (1993) The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 268: 10739-10745.
4. Doggen CJ, Bertina RM, Cats VM, et al. (1999) The 4G=5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction. Thromb Haemost 82:115-120.
5. Eriksson P, Kallin B, van't Hooft FM, et al. (1995) Allele-specific increase in basal transcription of the plasminogen-activator inhibitor-1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 92:1851-1855.
6. Eriksson P, Nilsson L, Karpe F, Hamsten A (1998) Very-lowdensity lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia. Arterioscler Thromb Vasc Biol 18:20-26.
7. Grenett HE, Benza RL, Fless GM, et al. (1998) Genotype-specific transcriptional regulation of PAI-1 gene by insulin, hypertriglyceridemic VLDL, and Lp(a) in transfected, cultured human endothelial cells. Arterioscler Thromb Vasc Biol 18: 1803-1809.
8. Grubic N, Stegnar M, Peternel P, et al. (1996) A novel G=A and the 4G=5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis. Thromb Res 84:431-443. (Pubitemid 27033603)
9. Henry M, Chomiki N, Scarabin PY, et al. (1997) Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population. Arterioscler Thromb Vasc Biol 17:851-858.
10. Iwai N, Shimoike H, Nakamura Y, et al. (1998) The 4G=5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes. Atherosclerosis 136:109-114.
11. Kohler HP, Grant PJ (2000) Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 342:1792-1801.
12. Loskutoff DJ, Linders M, Keijer J, et al. (1987) Structure of the human plasminogen activator inhibitor 1 gene: nonrandom distribution of introns. Biochemistry 26:3763-3768.
13. Mansfield MW, Stickland MH, Grant PJ (1995) Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus. Thromb Haemost 74:842-847.
14. Marenberg ME, Risch N, Berkman LF, et al. (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330:1041-1046.
15. Margaglione M, Cappucci G, Colaizzo D, et al. (1998) The PAI-1 gene locus 4G=5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol 18:152-156. (Pubitemid 28277590)
16. Meade TW, Ruddock V, Stirling Y, et al. (1993) Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 342:1076-1079.
17. Morange PE, Henry M, Tregouet D, et al. (2000) The A-844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers. Arterioscler Thromb Vasc Biol 20:1387-1391.
18. Nora JJ, Lortscher RH, Spangler RD, et al. (1980) Geneticepidemiologic study of early-onset ischemic heart disease. Circulation 61:503-508.
19. Ossei-Gerning N, Mansfield MW, Stickland MH, et al. (1997) Plasminogen activator inhibitor-1 promoter 4G=5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography. Arterioscler Thromb Vasc Biol 17:33-37.
20. Ridker PM, Hennekens CH, Lindpaintner K, et al. (1997) Arterial and venous thrombosis is not associated with the 4G=5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation 95:59-62.
21. Ridker PM, Vaughan DE, Stampfer MJ, et al. (1993) Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 341:1165-1168.
22. Van Harmelen V, Wahrenberg H, Eriksson P, Arner P (2000) Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue. Thromb Haemost 83:304-308.
23. Yang Q, Khoury MJ, Botto L, et al. (2003) Improving the prediction of complex diseases by testing for multiple diseasesusceptibility genes. Am J Hum Genet 72:636-649.
24. Ye S, Green FR, Scarabin PY, et al. (1995) The 4G=5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Thromb Haemost 74:837-841.